Literature DB >> 22427141

Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.

Feng Chen1, Deyong Yang, Xiangyu Che, Jianbo Wang, Xiancheng Li, Zhiwei Zhang, Xiaochi Chen, Xishuang Song.   

Abstract

Livin is a member of the family of inhibitors of apoptosis proteins (IAPs) and tumor cell invasion is a general property of multiple IAPs. Livin is highly expressed in prostate cancer (PCa) tissues. Livin overexpressing cells are more resistant to apoptotic stimuli than normal cells. Thus, aberrantly increased cell survival is an invariable requirement of metastasis. In this study, we investigated whether livin signaling affects metastasis by transfecting siRNA targeting livin into the DU-145 prostate cancer cell line to confirm the anti-invasion effect and blockade of the livin gene. We found that livin knockdown inhibited DU-145 prostate carcinoma cell invasion. We investigated how livin promotes tumor cell invasion, and found that livin induction of fibronectin contributed to tumor cell invasion. In addition, we found that livin induction of fibronectin regulates tumor cell invasion via nuclear factor κB (NF-κB) signaling. These data showed that livin, as a gene directly promoting metastasis, can be useful for therapeutic intervention against advanced and disseminated PCa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22427141     DOI: 10.3892/or.2012.1730

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.

Authors:  Yi Yang; Peng Sun; Wei Xu; Wei Xia
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

2.  PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma.

Authors:  Pei-Chuan Li; Shih-Yi Chen; Danzhou Xiangfei; Canquan Mao; Chieh-His Wu; Jean Chen Shih
Journal:  BMC Complement Med Ther       Date:  2020-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.